Ye Devlopment Company

BEIJING -- China's tech giant Tencent has released TAD Sim 2.0, the new generation of its autonomous-driving simulation platform, to improve the development and testing efficiency of autonomous driving. Simulation has been widely used in self-driving technology development and urban smart-transportation management. Tencent's new platform, driven by both real data and gaming technology, has a built-in centimeter-level digital map, as well as dynamic and static environments for autonomous driving testing. Compared with the previous generation, TAD Sim 2.0 fills the gap between road test data and virtual scenarios. With higher resolution in 3D scenario reconstruction and sensor simulation, the platform can make the simulation closer to reality. A huge variety of environments, weather conditions and even extreme traffic conditions can be generated by combining road test data and virtual scenarios to fulfill the needs of autonomous driving testing in TAD Sim 2.0. Accordin

China's homegrown BeiDou Navigation Satellite System, which is currently used for weather and earthquake forecasts, land surveys and mapping as well as for navigation of taxis, buses and trucks, has found a new home in the bike-sharing sector as companies are using the technology for better operations and user experiences. Bike-sharing companies have started using the system in a big way after the final satellite in the BeiDou navigation system was launched last week. Shanghai-based bike sharing company Hello Global has brought all its sharing bikes under the BeiDou umbrella, while Qingju Bike, owned by ride-hailing major Didi Chuxing, has put into operation shared bikes using the BeiDou services in Shenzhen of Guangdong province, Wuhan of the Hubei province and Beijing. Meituan Bike (formerly Mobike) has established an internet of things platform with millions of shared bikes backed by the BeiDou technology. Li Kaizhu, co-founder and executive-president of Hello Global, sai

RABAT -- Chinese technology firm Huawei and the Islamic Educational, Scientific and Cultural Organization (ICESCO) on Wednesday agreed to boost cooperation in the fields of education and artificial intelligence. During a meeting between deputy general director of Huawei in Morocco Zhu Yuan and director general of ICESCO Salem Ben Mohamed Al-Malik, cooperation in the research related to technology was also discussed, the Rabat-based organization said in a statement. Zhu praised the ICESCO's work to support efforts to fight the COVID-19 pandemic, noting Huawei attaches great importance to its social responsibility and has provided assistance to local communities in the countries where Huawei operates. Huawei is very focused on granting scholarships to students from these countries to continue their studies in the field of technology in China, he said. For his part, Al-Malik said ICESCO adopted a new vision to opening up to countries that are not members of the organization,

BEIJING - The number of mobile apps expanded in the Chinese market in May while those for music and video reported robust downloads. About 3.6 million mobile apps were available in China by the end of May, up 0.3 percent month-on-month, data from the Ministry of Industry and Information Technology showed. Mobile games continued to lead the apps in number, accounting for 24.9 percent of the total, followed by daily tools, e-commerce and life services apps. Music and video apps reported the most downloads, followed by mobile games, daily tools, and social networking and communication tools, the data showed.

Like many medications, the wakefulness drug modafinil, which is marketed under the trade name Provigil, comes with a small, tightly folded paper pamphlet. For the most part, its contents—lists of instructions and precautions, a diagram of the drug’s molecular structure—make for anodyne reading. The subsection called “Mechanism of Action,” however, contains a sentence that might induce sleeplessness by itself: “The mechanism(s) through which modafinil promotes wakefulness is unknown.” Provigil isn’t uniquely mysterious. Many drugs receive regulatory approval, and are widely prescribed, even though no one knows exactly how they work. This mystery is built into the process of drug discovery, which often proceeds by trial and error. Each year, any number of new substances are tested in cultured cells or animals; the best and safest of those are tried out in people. In some cases, the success of a drug promptly inspires new research that ends up explaining how it works—but not always.